The US Food and Drug Administration will no longer consider eight medical software functions as medical devices, which removes them from regulatory oversight. The rule makes it easier for manufacturers of such software to develop and update their product as long as it fits within the agency’s narrow definition for exclusion.
The FDA on 16 April published a final rule that goes into effect on 19 April that excludes the eight medical device classification regulations that were amended to exclude software functions that are not medical devices.. While very sudden, the rule has been a long time coming and is required under the 21st Century Cures Act that was enacted in late 2016
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?